Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research on breast cancer discussed by J.P. Yu and co-researchers
August 28th, 2008
"Cytokine-induced killer cells (CIKs) are nonspecific antitumor effectors with superior advantages. CD4(+) CIKs can induce Fas-dependent apoptosis in sensitive Raji cells," scientists writing in the journal Cancer Biotherapy and Radiopharmaceuticals report. "Here, a Fas-dependent apoptosis was detected in resistant breast cancer MDA-MB-231 cells, and underlying mechanisms were discriminated. Amplification of CIKs and purification of CD4(+) CIKs were performed in 15 patients with malignant solid tumors. The expression of CD40L and soluble cytokines in CD4(+) CIKs were analyzed. The apoptotic rates of tumor cells and the expression of Fas on membranes were detected...
Source: Women's Health Weekly (2008-08-28)
|
